AI assistant
Sending…
AbbVie Inc. — Capital/Financing Update 2016
Nov 18, 2016
29755_prs_2016-11-18_27e57097-860e-4e7a-af81-fe3beb5ea888.html
Capital/Financing Update
Open in viewerOpens in your device viewer
AbbVie Inc. Prospectus Supplement
NORTH CHICAGO, Illinois, November 18, 2016 /PRNewswire/ --
AbbVie Inc. has filed From 424B5, form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3, with the AMF. The full document can be viewed at http://www.abbvieinvestor.com/phoenix.zhtml?c=251551&p=irol-sec#14674069
This is a disclosure announcement from PR Newswire.
More from AbbVie Inc.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4